- Home
- UNH vs AZN Comparison
UNH vs AZN Comparison
Compare UNH & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNH | AZN |
|---|---|---|
| Founded | 1977 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.9B | 276.3B |
| IPO Year | 1984 | 1993 |
Fundamental Metrics
Financial Performance| Metric | UNH | AZN |
|---|---|---|
| Price | $330.00 | $90.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 2 |
| Target Price | ★ $407.88 | N/A |
| AVG Volume (30 Days) | ★ 7.7M | 5.5M |
| Earning Date | 01-15-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.67% | 1.70% |
| EPS Growth | 24.92 | ★ 45.02 |
| EPS | ★ 19.22 | 6.02 |
| Revenue | ★ $435,159,000,000.00 | $58,127,000,000.00 |
| Revenue This Year | $12.94 | $11.33 |
| Revenue Next Year | $1.55 | $6.08 |
| P/E Ratio | ★ $17.22 | $29.88 |
| Revenue Growth | 10.47 | ★ 13.52 |
| 52 Week Low | $234.60 | $61.24 |
| 52 Week High | $608.99 | $94.02 |
Technical Indicators
Market Signals| Indicator | UNH | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 57.45 |
| Support Level | $322.80 | $89.77 |
| Resistance Level | $341.41 | $91.28 |
| Average True Range (ATR) | 8.63 | 1.35 |
| MACD | 2.34 | -0.29 |
| Stochastic Oscillator | 69.07 | 31.49 |
Price Performance
Historical ComparisonAbout UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.